Encephalomyelitis: Clinical Trials

3 trials for Encephalomyelitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 active not recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 3

Follow Encephalomyelitis: new trials by email Literature Review of Encephalomyelitis trials Research Report on Encephalomyelitis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine
MVA-BN-WEV, Placebo - Encephalitis
Phase 2Active not recruitingBavarian Nordic4112025-03-102025-10-01
Study to Investigate Improvement in Physical Function in SF-36 With Vericiguat Compared With Placebo in Participants With Post-COVID-19 Syndrome
Vericiguat Oral Tablet - Post-COVID ME/CFS
Phase 2Active not recruitingCharite University, Berlin, Germany1042023-06-222026-01-28
Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
NAC 900mg/day, NAC 3600mg/day, NAC 0mg/day (Placebo) - Chronic Fatigue Syndrome, Myalgic Encephalomyelitis
Phase 2Active not recruitingWeill Medical College of Cornell University952020-09-012026-06-22

Narrower conditions

Fatigue Syndrome, Chronic (2)  ·  Encephalitis (1)  ·  Encephalomyelitis, Equine (1)  ·  Post-Acute COVID-19 Syndrome (1)

Broader conditions

Nervous System Diseases (3)  ·  Neuroinflammatory Diseases (3)  ·  Chronic Disease (2)  ·  Disease Attributes (2)  ·  Infections (2)  ·  Muscular Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Neuromuscular Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  RNA Virus Infections (2)  ·  Virus Diseases (2)  ·  Alphavirus Infections (1)  ·  Arbovirus Infections (1)

Interventions

vericiguat (1)

Sponsors

Bavarian Nordic (1)  ·  Charite University, Berlin, Germany (1)  ·  Weill Medical College of Cornell University (1)

Countries

United States (2)  ·  Germany (1)

Top investigators

Carlos A. Fierro, MD (1)  ·  Dikoma C. Shungu, Ph.D. (1)  ·  Judith Bellmann-Strobl, MD (1)

NIH funding

R01NS116887 (1)